GRAIL, Inc. Costs and Expenses
GRAIL, Inc. (GRAL) reported Costs and Expenses of $218.47 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-06
- GRAIL, Inc. costs and expenses for the quarter ending 2026-06-30 was $218.47M, a 12.38% increase year-over-year.
- GRAIL, Inc. costs and expenses for the quarter ending 2026-03-31 was $176.55M, a 4.80% decline year-over-year.
- GRAIL, Inc. costs and expenses for the quarter ending 2025-12-31 was $168.01M, a 4.10% decline year-over-year.
- GRAIL, Inc. costs and expenses for the quarter ending 2025-09-30 was $161.49M, a 23.88% decline year-over-year.
- GRAIL, Inc. costs and expenses for fiscal 2025 was $709.34M, a 69.36% decline from fiscal 2024.
- GRAIL, Inc. costs and expenses for fiscal 2024 was $2.31B, a 43.91% increase from fiscal 2023.
- GRAIL, Inc. costs and expenses for fiscal 2023 was $1.61B, a 70.75% decline from fiscal 2023.
- GRAIL, Inc. costs and expenses for fiscal 2023 was $5.50B.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $218.47M 10-Q · filed 2026-08-06 | $395.02M 10-Q · filed 2026-08-06 | $563.03M derived: sum of 3 quarters · filed 2026-08-06 | $724.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $176.55M 10-Q · filed 2026-05-07 | $344.56M derived: sum of 2 quarters · filed 2026-05-07 | $506.04M derived: sum of 3 quarters · filed 2026-05-07 | $700.44M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $168.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $329.49M derived: sum of 2 quarters · filed 2026-03-12 | $523.89M derived: sum of 3 quarters · filed 2026-08-06 | $709.34M 10-K · filed 2026-03-12 |
| 2025-09-30 | $161.49M 10-Q · filed 2025-11-13 | $355.88M derived: sum of 2 quarters · filed 2026-08-06 | $541.33M 10-Q · filed 2025-11-13 | $716.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $194.40M 10-Q · filed 2026-08-06 | $379.84M 10-Q · filed 2026-08-06 | $555.03M derived: sum of 3 quarters · filed 2026-08-06 | $767.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $185.44M 10-Q · filed 2026-05-07 | $360.63M derived: sum of 2 quarters · filed 2026-05-07 | $572.79M derived: sum of 3 quarters · filed 2026-05-07 | $2.25B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $175.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $387.35M derived: sum of 2 quarters · filed 2026-03-12 | $2.06B derived: sum of 3 quarters · filed 2026-03-12 | $2.31B 10-K · filed 2026-03-12 |
| 2024-09-30 | $212.16M 10-Q · filed 2025-11-13 | $1.89B derived: sum of 2 quarters · filed 2025-11-13 | $2.14B 10-Q · filed 2025-11-13 | $2.36B derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | $1.67B 10-Q · filed 2025-08-13 | $1.93B 10-Q · filed 2025-08-13 | $2.15B derived: sum of 3 quarters · filed 2026-03-12 | $3.09B derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $254.14M 10-Q · filed 2025-05-14 | $479.06M derived: sum of 2 quarters · filed 2026-03-12 | $1.41B derived: sum of 3 quarters · filed 2026-03-12 | $1.64B derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | $224.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.16B derived: sum of 2 quarters · filed 2026-03-12 | $1.38B derived: sum of 3 quarters · filed 2026-03-12 | $1.61B 10-K · filed 2025-03-05 |
| 2023-10-01 | $933.11M 10-Q · filed 2024-11-13 | $1.16B derived: sum of 2 quarters · filed 2024-11-13 | $1.38B 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $226.78M 10-Q · filed 2024-08-13 | $450.45M 10-Q · filed 2024-08-13 | ||
| 2023-01-01 | $5.50B 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |